BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 12966366)

  • 21. Characterization of the induction of nitric oxide synthase and cyclo-oxygenase in rat aorta in organ culture.
    Bishop-Bailey D; Larkin SW; Warner TD; Chen G; Mitchell JA
    Br J Pharmacol; 1997 May; 121(1):125-33. PubMed ID: 9146896
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Celecoxib and curcumin synergistically inhibit the growth of colorectal cancer cells.
    Lev-Ari S; Strier L; Kazanov D; Madar-Shapiro L; Dvory-Sobol H; Pinchuk I; Marian B; Lichtenberg D; Arber N
    Clin Cancer Res; 2005 Sep; 11(18):6738-44. PubMed ID: 16166455
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vitro and ex vivo inhibition of canine cyclooxygenase isoforms by robenacoxib: a comparative study.
    King JN; Rudaz C; Borer L; Jung M; Seewald W; Lees P
    Res Vet Sci; 2010 Jun; 88(3):497-506. PubMed ID: 20004922
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Classic NSAID and selective cyclooxygenase (COX)-1 and COX-2 inhibitors in healing of chronic gastric ulcers.
    Brzozowski T; Konturek PC; Konturek SJ; Sliwowski Z; Pajdo R; Drozdowicz D; Ptak A; Hahn EG
    Microsc Res Tech; 2001 Jun; 53(5):343-53. PubMed ID: 11376495
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Participation of cyclooxygenase-1 in prostaglandin E2 release from synovitis tissue in primary osteoarthritis in vitro.
    Knorth H; Dorfmüller P; Lebert R; Schmidt WE; Wittenberg RH; Heukamp M; Wiese M; Willburger RE
    Osteoarthritis Cartilage; 2004 Aug; 12(8):658-66. PubMed ID: 15262246
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Induction of an acetaminophen-sensitive cyclooxygenase with reduced sensitivity to nonsteroid antiinflammatory drugs.
    Simmons DL; Botting RM; Robertson PM; Madsen ML; Vane JR
    Proc Natl Acad Sci U S A; 1999 Mar; 96(6):3275-80. PubMed ID: 10077674
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of the cyclooxygenase-1 inhibitory properties of nonsteroidal anti-inflammatory drugs (NSAIDs) and selective COX-2 inhibitors, using sensitive microsomal and platelet assays.
    Riendeau D; Charleson S; Cromlish W; Mancini JA; Wong E; Guay J
    Can J Physiol Pharmacol; 1997 Sep; 75(9):1088-95. PubMed ID: 9365818
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Imrecoxib: a novel and selective cyclooxygenase 2 inhibitor with anti-inflammatory effect.
    Chen XH; Bai JY; Shen F; Bai AP; Guo ZR; Cheng GF
    Acta Pharmacol Sin; 2004 Jul; 25(7):927-31. PubMed ID: 15210067
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Stereoselective inhibition of inducible cyclooxygenase by chiral nonsteroidal antiinflammatory drugs.
    Carabaza A; Cabré F; Rotllan E; Gómez M; Gutiérrez M; García ML; Mauleón D
    J Clin Pharmacol; 1996 Jun; 36(6):505-12. PubMed ID: 8809635
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Generation of 8-epi-prostaglandin F(2alpha) in isolated rat kidney glomeruli by a radical-independent mechanism.
    Klein T; Neuhaus K; Reutter F; Nüsing RM
    Br J Pharmacol; 2001 Jul; 133(5):643-50. PubMed ID: 11429387
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of cyclooxygenase-2 expression by 4-trifluoromethyl derivatives of salicylate, triflusal, and its deacetylated metabolite, 2-hydroxy-4-trifluoromethylbenzoic acid.
    Fernández de Arriba A; Cavalcanti F; Miralles A; Bayón Y; Alonso A; Merlos M; García-Rafanell J; Forn J
    Mol Pharmacol; 1999 Apr; 55(4):753-60. PubMed ID: 10101034
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of antiinflammatory drugs on COX-1 and COX-2 activity in human articular chondrocytes.
    Blanco FJ; Guitian R; Moreno J; de Toro FJ; Galdo F
    J Rheumatol; 1999 Jun; 26(6):1366-73. PubMed ID: 10381057
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Etoricoxib (MK-0663): preclinical profile and comparison with other agents that selectively inhibit cyclooxygenase-2.
    Riendeau D; Percival MD; Brideau C; Charleson S; Dubé D; Ethier D; Falgueyret JP; Friesen RW; Gordon R; Greig G; Guay J; Mancini J; Ouellet M; Wong E; Xu L; Boyce S; Visco D; Girard Y; Prasit P; Zamboni R; Rodger IW; Gresser M; Ford-Hutchinson AW; Young RN; Chan CC
    J Pharmacol Exp Ther; 2001 Feb; 296(2):558-66. PubMed ID: 11160644
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The analgesic NSAID lornoxicam inhibits cyclooxygenase (COX)-1/-2, inducible nitric oxide synthase (iNOS), and the formation of interleukin (IL)-6 in vitro.
    Berg J; Fellier H; Christoph T; Grarup J; Stimmeder D
    Inflamm Res; 1999 Jul; 48(7):369-79. PubMed ID: 10450786
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Constitutive cyclooxygenase-1 and induced cyclooxygenase-2 in isolated human iris inhibited by S(+) flurbiprofen.
    van Haeringen NJ; van Sorge AA; Carballosa Coré-Bodelier VM
    J Ocul Pharmacol Ther; 2000 Aug; 16(4):353-61. PubMed ID: 10977131
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Rofecoxib [Vioxx, MK-0966; 4-(4'-methylsulfonylphenyl)-3-phenyl-2-(5H)-furanone]: a potent and orally active cyclooxygenase-2 inhibitor. Pharmacological and biochemical profiles.
    Chan CC; Boyce S; Brideau C; Charleson S; Cromlish W; Ethier D; Evans J; Ford-Hutchinson AW; Forrest MJ; Gauthier JY; Gordon R; Gresser M; Guay J; Kargman S; Kennedy B; Leblanc Y; Leger S; Mancini J; O'Neill GP; Ouellet M; Patrick D; Percival MD; Perrier H; Prasit P; Rodger I
    J Pharmacol Exp Ther; 1999 Aug; 290(2):551-60. PubMed ID: 10411562
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibition of PGE2 production by nimesulide compared with diclofenac in the acutely inflamed joint of patients with arthritis.
    Duffy T; Belton O; Bresnihan B; FitzGerald O; FitzGerald D
    Drugs; 2003; 63 Suppl 1():31-6. PubMed ID: 14506909
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [COX-1 and COX-2: functions and pharmacological effects].
    Hinz B; Brune K
    Pharm Unserer Zeit; 1999 Jan; 28(1):21-9. PubMed ID: 10078026
    [No Abstract]   [Full Text] [Related]  

  • 39. Experimental models used to investigate the differential inhibition of cyclooxygenase-1 and cyclooxygenase-2 by non-steroidal anti-inflammatory drugs.
    Pairet M; van Ryn J
    Inflamm Res; 1998 Oct; 47 Suppl 2():S93-101. PubMed ID: 9831330
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The pyrrole moiety as a template for COX-1/COX-2 inhibitors.
    Dannhardt G; Kiefer W; Krämer G; Maehrlein S; Nowe U; Fiebich B
    Eur J Med Chem; 2000 May; 35(5):499-510. PubMed ID: 10889329
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.